Xconomy National

Archives

by in

Entry	Author	Date	Location
Seattle Genetics Sees Updated Side Effect Warning in Drug Label	Luke Timmerman	01/13/12	Seattle
Seattle Genetics: The Next Litmus Test for High Priced Cancer Drugs	Luke Timmerman	08/22/11	National
Seattle Genetics’ FDA Panel Preview: What You Need to Know This Week	Luke Timmerman	07/12/11	Seattle
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul	Luke Timmerman	07/05/11	Seattle
Dendreon Moves Across Town, SeaGen Files FDA App, Alder Takes Road Less Traveled, & More Seattle Life Sciences News	Luke Timmerman	03/03/11	Seattle
SEC Accuses Seattle Genetics Employee of Insider Trading	Luke Timmerman	01/21/11	Seattle
Seattle Genetics Gets Some Love on National TV, as Cancer Drug Nears Market	Luke Timmerman	01/14/11	Seattle
Editor’s Picks: The Best of 2010 From Xconomy Seattle	Luke Timmerman	12/23/10	Seattle
Seattle Genetics’ Home Run, NanoString’s Diagnostics Foray, PATH’s 50-Cent Vaccine, & More Seattle-Area Life Sciences News	Luke Timmerman	12/09/10	Seattle
Seattle Genetics, Millennium’s Encore: Souped-Up Antibody Looks Better in 2nd Trial	Luke Timmerman	12/07/10	Seattle
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s	Luke Timmerman	12/05/10	Seattle
Seattle Genetics, Millennium Nail 2nd Straight Trial With “Empowered Antibody” For Cancer	Luke Timmerman	10/11/10	Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer	Luke Timmerman	09/27/10	Seattle
Larry Corey, Virus Hunter With Midwest Roots, Seeks to Unleash Health Innovation at Hutch	Luke Timmerman	08/02/10	Seattle
Seattle Genetics’ Dark Horse, Gilead Beats Novartis, Oncothyreon Back in the Saddle, & More Seattle-Area Life Sciences News	Luke Timmerman	06/24/10	Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News	Luke Timmerman	06/11/10	Seattle
Seattle Genetics Shows Re-Treatment Action	Luke Timmerman	06/05/10	Seattle
Seattle Genetics, Growing Up in a Hurry With Millennium, Aims to Make Most of Cancer Drug	Luke Timmerman	05/26/10	Seattle
Seattle Genetics Adds Patent to 2025	Luke Timmerman	03/11/10	Seattle
Seattle Genetics Starts Lymphoma Trial	Luke Timmerman	02/03/10	Seattle
Accelerator Slowed Down, Inside the Latest Seattle Genetics Deal, Ekos Finds New Use, & More Seattle-Area Life Sciences News	Luke Timmerman	01/28/10	Seattle
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News	Luke Timmerman	10/15/09	Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News	Luke Timmerman	08/27/09	Seattle
Seattle Genetics Trial Fills Up	Luke Timmerman	08/24/09	Seattle
Seattle Genetics Gets $136M Total	Luke Timmerman	08/13/09	Seattle
Seattle Genetics, Bucking the Trend, Recruits Hodgkin’s Patients at Warp Speed	Luke Timmerman	08/12/09	Seattle
Seattle Genetics Starts New Trial	Luke Timmerman	06/18/09	Seattle
Cell Therapeutics Shares Boom, Vulcan’s Breast Cancer Bombshell, Microsoft Buys Rosetta Assets, & More Seattle-Area Life Sciences News	Luke Timmerman	06/04/09	Seattle
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results	Luke Timmerman	06/01/09	Seattle
Seattle Genetics “Empowered Antibody” Wipes Out Hodgkin’s Tumors in Early Study	Luke Timmerman	06/01/09	Seattle
Page 1 of 2	next page »